HCM
VIVO

Hollencrest Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Hollencrest Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,400
Closed -$179K – 1202
2022
Q4 		$179K Buy
+5,400
New +$174K 0.02% 263
2018
Q2 		– Sell
-35,400
Closed -$503K – 348
2018
Q1 		$503K Hold
35,400
– – 0.07% 169
2017
Q4 		$496K Hold
35,400
– – 0.07% 169
2017
Q3 		$506K Hold
35,400
– – 0.07% 168
2017
Q2 		$558K Hold
35,400
– – 0.08% 150
2017
Q1 		$489K Hold
35,400
– – 0.07% 181
2016
Q4 		$627K Hold
35,400
– – 0.09% 140
2016
Q3 		$683K Hold
35,400
– – 0.1% 147
2016
Q2 		$690K Hold
35,400
– – 0.11% 149
2016
Q1 		$729K Hold
35,400
– – 0.12% 131
2015
Q4 		$727K Hold
35,400
– – 0.13% 136
2015
Q3 		$605K Hold
35,400
– – 0.1% 140
2015
Q2 		$660K Hold
35,400
– – 0.09% 144
2015
Q1 		$675K Hold
35,400
– – 0.09% 151
2014
Q4 		$583K Buy
35,400
+5,400
+18% +$92.6K 0.08% 180
2014
Q3 		$531K Buy
+30,000
New +$589K 0.07% 185

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hollencrest Capital Management's VIVO Position: Q1 2023 in Review

Hollencrest Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 5,400 shares — an estimated $179K sold.

Hollencrest Capital Management first reported a position in VIVO in Q3 2014 and held it in 16 quarters. The position peaked at $729K in Q1 2016. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Hollencrest Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Hollencrest Capital Management sold 5,400 Meridian Bioscience Inc shares in Q1 2023, an estimated $179K.
  • Hollencrest Capital Management first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 16 quarters.
  • Hollencrest Capital Management's Meridian Bioscience Inc position peaked at $729K in Q1 2016.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Hollencrest Capital Management's 13F filing for Q1 2023, filed 16 May 2023.